This research was a phase 3 clinical trial involving people with metabolic dysfunction-associated steatohepatitis (MASH)
Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice
doi: 10.1056/NEJMoa2204601 24 SmitsMMVan RaalteDH
Tirzepatide produces more weight loss on average, and the data is now clear
If youve struggled to lose weight despite reasonable effort with diet and exercise, if you suspect hormones or thyroid might be involved, if youre curious about GLP-1s but cautious about how theyre prescribed online, or if youre already on one and want a clinical team behind you yes, a consultation is worth your time
High-yield reporting fields for suspected semaglutide-related vaginal symptoms include: dose and escalation dates, concomitant SGLT2 inhibitor use, antibiotic/antifungal use, menopausal status/HRT, diabetes control markers, symptom description with onset/offset, objective test results (pH, microscopy/NAAT), and dechallenge/rechallenge outcomes if they occur
